Nimotuzumab is a humanized monoclonal antibody that as of 2014 had orphan status in the US and EU for glioma, and marketing approval in India, China, and other countries for squamous cell carcinomas of the head and neck, and was undergoing several clinical trials.
Member Since 8 Years
Nature of Business Exporter
GST No. 24ASGPM4458E1ZS
For Buyer 
For Seller 
Help 
Bhatar, Surat, Gujarat